Short Interest in Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Rises By 458.7%

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) was the target of a large growth in short interest in January. As of January 30th, there was short interest totaling 757,655 shares, a growth of 458.7% from the January 15th total of 135,611 shares. Based on an average daily volume of 1,844,236 shares, the days-to-cover ratio is currently 0.4 days. Approximately 2.1% of the company’s stock are sold short. Approximately 2.1% of the company’s stock are sold short. Based on an average daily volume of 1,844,236 shares, the days-to-cover ratio is currently 0.4 days.

Adlai Nortye Price Performance

NASDAQ ANL opened at $9.74 on Wednesday. Adlai Nortye has a 52-week low of $0.88 and a 52-week high of $12.09. The business’s 50-day moving average price is $3.09 and its 200 day moving average price is $2.14.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Adlai Nortye in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Adlai Nortye currently has an average rating of “Reduce”.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.